Distribution of HPV genotypes in Mashhad, Iran: insights from a 2022–2023 study
In line with the results of this study, the prevalence of HPV genotypes in both genders is 30%. The results likely reflect differences in the prevalence of high-risk HPV genotypes, that are less common. Also, HPV-6 and HPV-16 genotypes that are covered by the vaccine had a significant prevalence. On the other hand, with the prevalence of HPV-51 and HPV-39 genotypes in infected people who are not covered by the Gardasil (quadrivalent) vaccine, there is a risk of related cancers in the future.
Authors
- Masoud Parsania (ORCID: https://orcid.org/0000-0002-4739-7442)
- Zahra Sadeghi (ORCID: https://orcid.org/0000-0003-3966-4720)
- Arash Letafati (ORCID: https://orcid.org/0000-0002-0415-0239)
- Omid Salahi Ardekani (ORCID: https://orcid.org/0000-0001-8498-5094)
- M J Gol Alipour
- Ali Vasheghani Farahani (ORCID: https://orcid.org/0009-0007-0783-6475)
- Tina Fallah
- Hossein Pourmoein
- Saba Yousefi Nodeh
- Shima Sadeghipoor
- Karimeh Heshmatipour
- Mohammad Mostafa Baradaran Nasiri
- Iman Rezaee Azhar
- Masoomeh Noroozi
Institutions
- University of Tehran (IR)
- Islamic Azad University Medical Branch of Tehran (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Virology Journal
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1186/s12985-024-02518-4
- Citations
- 3
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.16